Uganda, Tanzania Top In East Africa for Antiretroviral Use
Between October 2018 and June 2019, 93% of all people living with HIV in Uganda were on antiretroviral therapy as were those in Malawi, while Tanzania was at 86% and Kenya at 82%, according to an audit by the U.S. Department of State which is reviewing the HIV/Aids relief programme that the U.S. is offering to the three countries.
(file photo).
-
Uganda:
Disregard Cultural Practices That Spread HIV - Museveni
Monitor, 2 December 2019
President Museveni has advised Ugandans to do away with cultural practices that have contributed to the spread of HIV/Aids. Read more »
-
Uganda:
Increase Efforts Against HIV/Aids
Monitor, 2 December 2019
Uganda joined the rest of the world yesterday to commemorate World Aids Day. Read more »
-
Uganda:
HIV Stigma Has Dropped - Index Report
Monitor, 27 November 2019
Stigma against people living with external forms of HIV/Aids, including exclusion from social gatherings, physical and verbal harassment have comparatively reduced from 50 per cent… Read more »
-
Tanzania:
Tanzania Starts Using Effective HIV Drug
Citizen, 11 December 2019
Tanzania has started using Dolutegravir 'DGT', the new and most effective drug in suppressing HIV/Aids in the human body. Read more »
-
Tanzania:
Ministry Embarks On HIV/Aids Screening Drive for Men
Daily News, 27 September 2019
HEALTH, Community Development, Gender, Elderly and Children Ministry has embarked on 'Moonlight' pilot project to reach men in their hiding places and persuade them for HIV/AIDS… Read more »
InFocus
-
The government aims at stepping up Prevention of Mother to Child Transmission of HIV (PMTCT) measures to reach a 4% target in 2021 and has emphasised the need to engage with health ... Read more »
-
A mobile application 'PrEP Uganda' can now be downloaded from the Google Play Store for those who might need to get Pre-Exposure Prophylaxis (PrEP), a course of HIV drugs taken by ... Read more »
-
Uganda has partnered with U.S. based company Abbott to deploy different diagnostic tools. Among them is the m-PIMA HIV-1/2 VL, a portable molecular point-of-care viral load ... Read more »